Drug development for schizophrenia based on the pathogenesis from rare disease-susceptibility variants

Norio OZAKI

講演情報

[AsCNP] シンポジウム

AsCNP » [AsCNP] シンポジウム

[AsCNP_S25] シンポジウム25
Early detection and new intervention in psychiatric disorders: from rare diseases, schizophrenia, to dementia

2019年10月12日(土) 08:40 〜 10:20 第15会場 (パレスルームB)

Organizer / Chair: Norio OZAKI (Department of Psychiatry, Nagoya University Graduate School of Medicine, Japan), Co-chair: Makoto ARAI (Tokyo Metropolitan Institute of Medical Science, Japan), Discussant: ‌Tomiki SUMIYOSHI (National Center of Neurology and Psychiatry, Japan)

08:40 〜 09:02

[AsCNP-S25-1] Drug development for schizophrenia based on the pathogenesis from rare disease-susceptibility variants

^○Norio OZAKI (Department of Psychiatry, Nagoya University Graduate School of Medicine, Japan)

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードは事前参加登録者へメール、および参加証に印字してお送りします。プログラム抄録集の「大会参加者へのご案内」にも掲載しております。

講演情報

[AsCNP_S25] シンポジウム25Early detection and new intervention in psychiatric disorders: from rare diseases, schizophrenia, to dementia

[AsCNP-S25-1] Drug development for schizophrenia based on the pathogenesis from rare disease-susceptibility variants

パスワード

[AsCNP_S25] シンポジウム25
Early detection and new intervention in psychiatric disorders: from rare diseases, schizophrenia, to dementia